Pharmaceutical practice and value of pharmacists under the new medical reform situation

doi:10.5246/jcps.2018.09.065

Abstract

Abstract:

Zero addition of drugs is an important aspect of medication reformation in the whole country, which is the end of the era of medicine. The role of pharmacists is changing from being medication dispensers to outcome-oriented and patient-focused care providers. However, it is still unclear how to play the role of pharmacists and carry out the related work in the new situation. Here, literature for relevant evidence was searched and summarized. Analysis results showed that there was a significant gap between pharmacy practice in China and developed countries. Evidence has supported pharmacists in their emerging role as care providers, that is available to improve the efficacy and quality of pharmaceutical care and ensure the safety of medicines for patients, but still more efforts are needed to promote new attitude toward more professional career, such as paying attention to the examination of outpatient prescription and medical orders, deeply clinical practice and individualized treatment, self-enhancement and public awareness of pharmacists. Collectively, the safety of patients can be ensured only by improving profession of pharmacists and showing the value of pharmacists. In doing so, pharmacy can develop rapidly, and pharmaceutical care with rational drug use can be realized.

Key words: Pharmaceutical practice, Value of pharmacists, Patient care, Clinical Pharmacy

CLC Number:

R951

Supporting:

Shuyun Feng, Jinhui Guo, Yizhong Lu. Pharmaceutical practice and value of pharmacists under the new medical reform situation[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(9): 630-636.

References

[1] Bjorkman, I.K.; Sanner, M.A.; Bernsten, C.B. Comparing 4 classification systems for drug-related problems: processes and functions. Res. Social Adm. Pharm. 2008, 4, 320-331.

[2] Awalom, M.T.; Kidane, M.E.; Abraha, B.W. Physicians’ views on the professional roles of pharmacists in patient care in Eritrea. Int. J. Clin. Pharm. 2013, 35, 841-846.

[3] Richardson, T.E.; O'reilly, C.L.; Chen, T.F. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int. J. Clin. Pharm. 2014, 36, 222-232.

[4] Van Mil, J.W.; Fernandez-Llimos, F. What is ‘pharmaceutical care’ in 2013? Int. J. Clin. Pharm. 2013, 35, 1-2.

[5] Holland, R.W.; Nimmo, C.M. Transitions, part 1: beyond pharmaceutical care. Am. J. Health Syst. Pharm. 1999, 56, 1758-1764.

[6] Nimmo, C.M.; Holland, R.W. Transitions in pharmacy practice, part 2: who does what and why. Am. J. Health Syst. Pharm. 1999, 56, 1981-1987.

[7] Weiss, M.C.; Sutton, J. The changing nature of prescribing: pharmacists as prescribers and challenges to medical dominance. Social Health Illn. 2009, 31, 406-421.

[8] Keely, J.L. American College of Physicians-American Society of Internal M. Pharmacist scope of practice. Ann. Intern. Med. 2002, 136, 79-85.

[9] Jiang, S.P.; Zheng, X.; Li, X. Effectiveness of pharmaceutical care in an intensive care unit from China. A pre- and post-intervention study. Saudi. Med. J. 2012, 33, 756-762.

[10] Awaisu, A.; Alsalimy, N. Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature. Res. Social Adm. Pharm. 2015, 11, 725-748.

[11] Fang, Y.; Yang, S.; Zhou, S. Community pharmacy practice in China: past, present and future. Int. J. Clin. Pharm. 2013, 35, 520-528.

[12] Oladapo A.O.; Rascati K.L. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States. J. Pharm. Pract. 2012, 25, 457-470.

[13] Mcdaniel, J.; Bass, L.; Pate, T. Doubling Pharmacist Coverage in the Intensive Care Unit: Impact on the Pharmacists' Clinical Activities and Team Members’ Satisfaction. Hosp. Pharm. 2017, 52, 564-569.

[14] Michalets, E.L.; Williams, C.; Park, I. Ten year experience with student pharmacist research within a health system and education center. Curr. Pharm. Teach. Learn. 2018, 10, 316-324.

[15] Hooper, R.; Adam, A.; Kheir, N. Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar. Drug Health Patient Saf. 2009, 1, 73-80.

[16] Chair, K.W.; Aistrope, D.S.; Ausili, J. The Report of the 2016-2017 Professional Affairs Standing Committee: Formally Embracing and Engaging Preceptors in the Academy- The Time Has Come. Am. J. Pharm. Educ. 2017, 81, S16.

[17] Utsumi, M.; Hirano, S.; Fujii, Y. Evaluation of the pharmacy practice program in the 6-year pharmaceutical education curriculum in Japan: community pharmacy practice program. J. Pharm. Health Care. Sci. 2015, 1, 27.

[18] Hosoya, O. Introduction: Interprofessional Education (IPE) and Pharmaceutical Education: Saitama Interprofessional Education Project. Yakugaku. Zasshi. 2017, 137, 847-852.

[19] Niki, K.; Takemura, M.; Kitagawa, K. The Present Implementation Status and Problems of Vital-signs Measurement by Community Pharmacists in Home Medical Care in Osaka. Yakugaku. Zasshi. 2018, 138, 243-250.

[20] Lin, S.Y.; Chen, K.S.; Lin, Y.Y. pH of preparations affecting the on-off drug penetration behavior through the thermo-responsive liquid crystal-embedded membrane. J. Control Release. 1998, 55, 13-20.

[21] Kennie-Kaulbach, N.; Farrell, B.; Ward, N. Pharmacist provision of primary health care: a modified Delphi validation of pharmacists’ competencies. BMC. Fam. Pract. 2012, 13, 27.

[22] Ryan, M.; Shao, H.; Yang, L. Clinical pharmacy education in China. Am. J. Pharm. Educ. 2008, 72, 129.

[23] Hong, S. Outcome analysis on the rotation practice course for the professional degree graduates of clinical pharmacy at Peking University. J. Chin. Pharm. Sci. 2016, 25, 140-144

[24] He Y.; Yang F.; Mu D. Examination of psychosocial predictors of Chinese hospital pharmacists’ intention to provide clinical pharmacy services using the theory of planned behaviour: a cross-sectional questionnaire study. BMJ. Open. 2016, 6, e012775.

[25] Rupp, M.T.; Deyoung, M.; Schondelmeyer, S.W. Prescribing problems and pharmacist interventions in community practice. Med. Care. 1992, 30, 926-940.

[26] Malfara, M.; Pernassi, M.; Aragon, D. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int. J. Clin. Pharm. 2018, 40, 513-519.

[27] Liqun, W. Assessment of the quality of randomized controlled trials on pharmaceutical care for asthmatic patients in journals of mainland China. J. Chin. Pharm. Sci. 2017, 26, 212-221.

[28] Yao, C. Practice and experience in integrated pharmaceutical care. The 4th Asian Conference on Clinical Pharmacy. Seoul, 24-26 July 2004.

[29] China Nonprescription Medicine Association. Blue paper: the industrial development of Chinese nonprescription medicine. 1st ed. Beijing: Chemical Industry Press. 2011. ISBN, 978712 2109101.

[30] China Pharmaceutical Association. “Pharmacist on your side” campaign. 2012. Accessed 18 Aug 2012.